Marchex, Inc. (NASDAQ:MCHX) Weekly Ratings as of Jun 29, 2018

June 29, 2018 - By Julia Strobel

Marchex, Inc. (NASDAQ:MCHX) Corporate Logo
Big Money Sentiment decreased to 0.91 in Q1 2018. It has change of 0.47, from 2017Q4’s 1.38. The ratio dropped due to Marchex, Inc. positioning: 10 sold and 22 reduced. 12 funds acquired positions and 17 increased positions. Investors holded 19.71 million in 2017Q4 but now own 19.31 million shares or 2.04% less.
Bridgeway Cap invested 0.01% of its capital in Marchex, Inc. (NASDAQ:MCHX). Employees Retirement Sys Of Ohio reported 0% in Marchex, Inc. (NASDAQ:MCHX). Natl Bank Of Ny Mellon Corp holds 0% of its capital in Marchex, Inc. (NASDAQ:MCHX) for 74,151 shs. Vanguard Group Incorporated accumulated 1.34M shs. Brandywine Mgmt Ltd Liability Co holds 0% or 22,437 shs. Citadel Advsr Lc owns 11,032 shs. Concourse Cap Ltd Com invested in 133,230 shs or 0.23% of the stock. S Squared Technology Ltd Liability invested in 2.39% or 1.02 million shs. Synovus holds 0.01% or 172,724 shs in its capital. Raymond James And Assocs has 104,874 shs for 0% of their capital. Dimensional Fund Ltd Partnership stated it has 0% in Marchex, Inc. (NASDAQ:MCHX). Connor Clark And Lunn Limited holds 0% or 95,700 shs in its capital. Macquarie Gp has 0% invested in Marchex, Inc. (NASDAQ:MCHX). Tudor Investment Et Al has 35,900 shs for 0% of their capital. Acadian Asset Mngmt Ltd Com holds 0.01% or 513,806 shs.

Marchex, Inc. registered $1.37 million net activity with 7 insider purchases and 0 insider sales since February 5, 2018.

Marchex, Inc. (NASDAQ:MCHX) Ratings Coverage

A total of 2 analysts rate Marchex (NASDAQ:MCHX) as follows: 1 “Buy”, 1 “Hold” and 0 “Sell”. Тherefore 50% are bullish. (NASDAQ:MCHX) has 2 ratings reports on Jun 29, 2018 according to StockzIntelligence. On Tuesday, February 13 the rating was maintained by Roth Capital with “Hold”. On Tuesday, June 12 the firm earned “Buy” rating by Northland Capital. Listed here are Marchex, Inc. (NASDAQ:MCHX) PTs and latest ratings.

12/06/2018 Broker: Northland Capital Rating: Buy New Target: $6.0000 Initiate
13/02/2018 Broker: Roth Capital Rating: Hold New Target: $3.4 Maintain

Ticker’s shares touched $3.07 during the last trading session after 0.65% change.Currently Marchex, Inc. is uptrending after 11.42% change in last June 29, 2017. MCHX has also 4,490 shares volume. MCHX underperformed by 1.15% the S&P500.

Marchex, Inc. operates as a mobile advertising analytics company.The company has $132.35 million market cap. The Company’s products include Marchex Call Analytics, an analytics technology platform that provides data and insights to measure the performance of mobile, online, and offline advertising for advertisers and small business resellers; and Marchex Search Analytics, a product for search marketers that drive phone calls from search campaigns, as well as attributes inbound phone calls made directly from paid search ads and landing pages to a keyword.Last it reported negative earnings. The firm also provides Marchex Display and Video Analytics, a product for marketers that buy digital display advertising, as well as measures the influence that display advertising has on inbound phone calls; Marchex Social Analytics, a product for marketers that buy social media advertising; and Marchex Call Marketplace, a mobile advertising network for businesses that depend on inbound phone calls to drive sales, as well as offer advertisers ad placements across various mobile and online media sources to deliver qualified calls to their businesses.

There’s a substantial Marchex, Inc. (NASDAQ:MCHX) news brought out by It’s a report titled: “Marchex Automotive Study Reveals the Cost of Saying “No” to Customers Over the Phone” on June 14, 2018.

Marchex, Inc. (NASDAQ:MCHX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: